Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darae Ko

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Diabetes Care|November 13, 2025
Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 DiabetesChan Mi Park, Saran Thanapluetiwong, Xiecheng Chen, et al.
Nature Reviews. Cardiology|April 8, 2016
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosisDarae Ko, Faisal Rahman, Renate B Schnabel, et al.
Current Cardiology Reports|February 16, 2023
Frailty and Cardiovascular Mortality: A Narrative ReviewDarae Ko, John A Bostrom, Saadia Qazi, et al.
Circulation. Cardiovascular Quality and Outcomes|August 27, 2025
Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase StudyDae Hyun Kim, Darae Ko, Daniel E Singer, et al.
Cardiovascular Research|March 22, 2021
New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillationJelena Kornej, Vanessa A Hanger, Ludovic Trinquart, et al.
Journal of the American Heart Association|February 14, 2022
Neck Circumference and Risk of Incident Atrial Fibrillation in the Framingham Heart StudyJelena Kornej, Honghuang Lin, Ludovic Trinquart, et al.
Scientific Reports|March 11, 2022
The association between social network index, atrial fibrillation, and mortality in the Framingham Heart StudyJelena Kornej, Darae Ko, Honghuang Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA TrialShao-Wei Lo, Darae Ko, Dae Hyun Kim, et al.
Geriatrics (Basel, Switzerland)|April 26, 2024
Assessment and Management of Atrial Fibrillation in Older Adults with FrailtyAndrea Nathalie Rosas Diaz, Aaron L Troy, Vladimir Kaplinskiy, et al.
BMC Medicine|July 29, 2021
Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart StudyJelena Kornej, Qiuxi Huang, Sarah R Preis, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Diabetes Care|November 13, 2025
Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 DiabetesChan Mi Park, Saran Thanapluetiwong, Xiecheng Chen, et al.
Nature Reviews. Cardiology|April 8, 2016
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosisDarae Ko, Faisal Rahman, Renate B Schnabel, et al.
Current Cardiology Reports|February 16, 2023
Frailty and Cardiovascular Mortality: A Narrative ReviewDarae Ko, John A Bostrom, Saadia Qazi, et al.
Circulation. Cardiovascular Quality and Outcomes|August 27, 2025
Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase StudyDae Hyun Kim, Darae Ko, Daniel E Singer, et al.
Cardiovascular Research|March 22, 2021
New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillationJelena Kornej, Vanessa A Hanger, Ludovic Trinquart, et al.
Journal of the American Heart Association|February 14, 2022
Neck Circumference and Risk of Incident Atrial Fibrillation in the Framingham Heart StudyJelena Kornej, Honghuang Lin, Ludovic Trinquart, et al.
Scientific Reports|March 11, 2022
The association between social network index, atrial fibrillation, and mortality in the Framingham Heart StudyJelena Kornej, Darae Ko, Honghuang Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA TrialShao-Wei Lo, Darae Ko, Dae Hyun Kim, et al.
Geriatrics (Basel, Switzerland)|April 26, 2024
Assessment and Management of Atrial Fibrillation in Older Adults with FrailtyAndrea Nathalie Rosas Diaz, Aaron L Troy, Vladimir Kaplinskiy, et al.
BMC Medicine|July 29, 2021
Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart StudyJelena Kornej, Qiuxi Huang, Sarah R Preis, et al.
Pageof 7